Johnson & Johnson Secures FDA Approval for Robotic Surgical Platform, Impacting Intuitive Surgical Stock
Intuitive Surgical (ISRG) stock declined on July 22 after Johnson & Johnson (JNJ) received FDA approval for its Ottava robotic surgical platform. This marks J&J's entry into the soft-tissue robotic surgery market and poses a direct challenge to ISRG, which has faced significant year-to-date losses.
Topics: competition FDA approval robotic surgery stock price movement